Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Comparison of FAF and SD-OCT Geographic Atrophy Lesion Area and Growth Rate Measurements
Author Affiliations & Notes
  • Jennifer Yen Luu
    Data Science and Digital Health, Janssen Research and Development LLC, Brisbane, California, United States
  • Tharindu De Silva
    Janssen Research and Development LLC, Raritan, New Jersey, United States
  • Sara Gale
    Janssen Research and Development LLC, Raritan, New Jersey, United States
  • Kristopher Standish
    Janssen Research and Development LLC, Raritan, New Jersey, United States
  • Saskia Houwing
    Janssen Research and Development LLC, Raritan, New Jersey, United States
  • Anthony Pepio
    Janssen Research and Development LLC, Raritan, New Jersey, United States
  • Daniel Chao
    Janssen Research and Development LLC, Raritan, New Jersey, United States
  • Seema Garg
    Janssen Research and Development LLC, Raritan, New Jersey, United States
  • Lucas McLaughlin
    Data Science and Digital Health, Janssen Research and Development LLC, Brisbane, California, United States
  • Rishi Singh
    Cleveland Clinic Martin Health, Stuart, Florida, United States
  • Footnotes
    Commercial Relationships   Jennifer Luu Johnson & Johnson Innovative Medicine, Genentech, Code E (Employment); Tharindu De Silva Johnson & Johnson Innovative Medicine, Code E (Employment); Sara Gale Johnson & Johnson Innovative Medicine, Code E (Employment); Kristopher Standish Johnson & Johnson Innovative Medicine, Code E (Employment); Saskia Houwing Johnson & Johnson Innovative Medicine, Code E (Employment); Anthony Pepio Johnson & Johnson Innovative Medicine, Code E (Employment); Daniel Chao Johnson & Johnson Innovative Medicine, Code E (Employment); Seema Garg Johnson & Johnson Innovative Medicine, Code E (Employment); Lucas McLaughlin Genentech, Code C (Consultant/Contractor), Johnson & Johnson Innovative Medicine, Code E (Employment); Rishi Singh Genentech, Regeneron, Alcon, Bausch and Lomb, Iveric, Apellis, Eyepoint, and Johnson & Johnson Innovative Medicine, Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 2283. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jennifer Yen Luu, Tharindu De Silva, Sara Gale, Kristopher Standish, Saskia Houwing, Anthony Pepio, Daniel Chao, Seema Garg, Lucas McLaughlin, Rishi Singh; Comparison of FAF and SD-OCT Geographic Atrophy Lesion Area and Growth Rate Measurements. Invest. Ophthalmol. Vis. Sci. 2024;65(7):2283.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : While fundus autofluorescence (FAF) is the primary imaging modality to measure geographic atrophy (GA) growth in clinical trials, spectral domain optical coherence tomography (SD-OCT) imaging is routinely used in clinical care. This work aims to establish the relationship between FAF and SD-OCT GA-related measurements, to utilize SD-OCT for GA progression assessment.

Methods : In an IRB approved study, 12 patients (24 eyes) with both FAF and SD-OCT acquired within 60 days as part of routine clinical care at Cleveland Clinic were included. 76 image-pairs in total were analyzed with an average longitudinal follow up= 505±330 days. Trained, in-house experts manually segmented GA lesions in FAF following hypofluorescent areas demarcating GA. In SD-OCT, areas with complete retinal pigment epithelium and outer retinal atrophy (cRORA) were detected at the B-scan level using an automated algorithm with manual verification of the output. B-scan level cRORA segmentations were projected to create a 2D enface map depicting the total area of GA comparable to the segmented area in FAF. Total GA lesion area measurements were compared between modalities at each longitudinal time point. GA growth rates measured using longitudinal time points that spanned more than 180 days from baseline were also compared between modalities.

Results : GA area (mean±SD) was 6.1±4.3mm2 (range: 0.0-15.3mm2) in FAF, 6.6±4.6mm2 (range: 0.0-13.8mm2) in SD-OCT, and correlated with R2=0.98 and mean area difference= 0.6±0.5mm2. Annual growth rate (mean±SD) was 0.8±0.6mm2/year in FAF, 1.1±0.9mm2/year in SD-OCT, and correlated with R2=0.60 and mean growth rate difference= 0.5±0.5mm2/year. Longitudinal changes in field of view (e.g., limited OCT field of view not capturing the entire lesion), areas with incomplete outer retinal atrophy appearing as hypofluorescent areas in FAF, inconsistent peripapillary atrophy annotation, and annotation variability proximal to fovea in FAF contributed to some measurement differences between the modalities.

Conclusions : FAF and SD-OCT total GA area measurements are highly correlated. While positive correlation was observed for growth rate measurements, smaller yearly growth in GA lesions resulted in decreased correlation coefficient. Accounting for factors contributing to differences across modalities could help minimize measurement variability when comparing incremental growth rates at short time intervals.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×